302 related articles for article (PubMed ID: 29033565)
1. Double-receptor-targeting multifunctional iron oxide nanoparticles drug delivery system for the treatment and imaging of prostate cancer.
Ahmed MSU; Salam AB; Yates C; Willian K; Jaynes J; Turner T; Abdalla MO
Int J Nanomedicine; 2017; 12():6973-6984. PubMed ID: 29033565
[TBL] [Abstract][Full Text] [Related]
2. Enhanced noscapine delivery using uPAR-targeted optical-MR imaging trackable nanoparticles for prostate cancer therapy.
Abdalla MO; Karna P; Sajja HK; Mao H; Yates C; Turner T; Aneja R
J Control Release; 2011 Feb; 149(3):314-22. PubMed ID: 21047537
[TBL] [Abstract][Full Text] [Related]
3. Molecular MR Imaging of Prostate Cancer by Specified Iron Oxide Nanoparticles With PSMA-11 Peptides: A Preclinical Study.
Ghorbani F; Aminzadeh B; Borji N; Soudmand S; Montazerabadi A
J Magn Reson Imaging; 2024 Jun; 59(6):2204-2214. PubMed ID: 37572082
[TBL] [Abstract][Full Text] [Related]
4. Dual-targeting Wnt and uPA receptors using peptide conjugated ultra-small nanoparticle drug carriers inhibited cancer stem-cell phenotype in chemo-resistant breast cancer.
Miller-Kleinhenz J; Guo X; Qian W; Zhou H; Bozeman EN; Zhu L; Ji X; Wang YA; Styblo T; O'Regan R; Mao H; Yang L
Biomaterials; 2018 Jan; 152():47-62. PubMed ID: 29107218
[TBL] [Abstract][Full Text] [Related]
5. Peptide-conjugated nanoparticles for targeted imaging and therapy of prostate cancer.
Yeh CY; Hsiao JK; Wang YP; Lan CH; Wu HC
Biomaterials; 2016 Aug; 99():1-15. PubMed ID: 27209258
[TBL] [Abstract][Full Text] [Related]
6. Drug/Dye-Loaded, Multifunctional PEG-Chitosan-Iron Oxide Nanocomposites for Methotraxate Synergistically Self-Targeted Cancer Therapy and Dual Model Imaging.
Lin J; Li Y; Li Y; Wu H; Yu F; Zhou S; Xie L; Luo F; Lin C; Hou Z
ACS Appl Mater Interfaces; 2015 Jun; 7(22):11908-20. PubMed ID: 25978458
[TBL] [Abstract][Full Text] [Related]
7. Gelatin-encapsulated iron oxide nanoparticles for platinum (IV) prodrug delivery, enzyme-stimulated release and MRI.
Cheng Z; Dai Y; Kang X; Li C; Huang S; Lian H; Hou Z; Ma P; Lin J
Biomaterials; 2014 Aug; 35(24):6359-68. PubMed ID: 24816364
[TBL] [Abstract][Full Text] [Related]
8. Synthesis Of PEG-Coated, Ultrasmall, Manganese-Doped Iron Oxide Nanoparticles With High Relaxivity For T
Xiao S; Yu X; Zhang L; Zhang Y; Fan W; Sun T; Zhou C; Liu Y; Liu Y; Gong M; Zhang D
Int J Nanomedicine; 2019; 14():8499-8507. PubMed ID: 31695377
[TBL] [Abstract][Full Text] [Related]
9. Multifunctional nanomedicine platform for concurrent delivery of chemotherapeutic drugs and mild hyperthermia to ovarian cancer cells.
Taratula O; Dani RK; Schumann C; Xu H; Wang A; Song H; Dhagat P; Taratula O
Int J Pharm; 2013 Dec; 458(1):169-80. PubMed ID: 24091153
[TBL] [Abstract][Full Text] [Related]
10. Polymeric biocompatible iron oxide nanoparticles labeled with peptides for imaging in ovarian cancer.
Shahdeo D; Roberts A; Kesarwani V; Horvat M; Chouhan RS; Gandhi S
Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35103283
[TBL] [Abstract][Full Text] [Related]
11. Temperature-tunable iron oxide nanoparticles for remote-controlled drug release.
Dani RK; Schumann C; Taratula O; Taratula O
AAPS PharmSciTech; 2014 Aug; 15(4):963-72. PubMed ID: 24821220
[TBL] [Abstract][Full Text] [Related]
12. Folic acid on iron oxide nanoparticles: platform with high potential for simultaneous targeting, MRI detection and hyperthermia treatment of lymph node metastases of prostate cancer.
Bonvin D; Bastiaansen JAM; Stuber M; Hofmann H; Mionić Ebersold M
Dalton Trans; 2017 Sep; 46(37):12692-12704. PubMed ID: 28914298
[TBL] [Abstract][Full Text] [Related]
13. Comparison of active, passive and magnetic targeting to tumors of multifunctional paclitaxel/SPIO-loaded nanoparticles for tumor imaging and therapy.
Schleich N; Po C; Jacobs D; Ucakar B; Gallez B; Danhier F; Préat V
J Control Release; 2014 Nov; 194():82-91. PubMed ID: 25178270
[TBL] [Abstract][Full Text] [Related]
14. PSMA targeted docetaxel-loaded superparamagnetic iron oxide nanoparticles for prostate cancer.
Nagesh PKB; Johnson NR; Boya VKN; Chowdhury P; Othman SF; Khalilzad-Sharghi V; Hafeez BB; Ganju A; Khan S; Behrman SW; Zafar N; Chauhan SC; Jaggi M; Yallapu MM
Colloids Surf B Biointerfaces; 2016 Aug; 144():8-20. PubMed ID: 27058278
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of T2* Weighted MRI Imaging Sensitivity of U87MG Glioblastoma Cells Using γ-Ray Irradiated Low Molecular Weight Hyaluronic Acid-Conjugated Iron Nanoparticles.
Huang HM; Wu PH; Chou PC; Hsiao WT; Wang HT; Chiang HP; Lee CM; Wang SH; Hsiao YC
Int J Nanomedicine; 2021; 16():3789-3802. PubMed ID: 34103915
[TBL] [Abstract][Full Text] [Related]
16. Tumor Penetrating Theranostic Nanoparticles for Enhancement of Targeted and Image-guided Drug Delivery into Peritoneal Tumors following Intraperitoneal Delivery.
Gao N; Bozeman EN; Qian W; Wang L; Chen H; Lipowska M; Staley CA; Wang YA; Mao H; Yang L
Theranostics; 2017; 7(6):1689-1704. PubMed ID: 28529645
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic effects and apoptosis induction of cisplatin-loaded iron oxide nanoparticles modified with chitosan in human breast cancer cells.
Morovati A; Ahmadian S; Jafary H
Mol Biol Rep; 2019 Oct; 46(5):5033-5039. PubMed ID: 31278563
[TBL] [Abstract][Full Text] [Related]
18. Cellular effects of paclitaxel-loaded iron oxide nanoparticles on breast cancer using different 2D and 3D cell culture models.
Lugert S; Unterweger H; Mühlberger M; Janko C; Draack S; Ludwig F; Eberbeck D; Alexiou C; Friedrich RP
Int J Nanomedicine; 2019; 14():161-180. PubMed ID: 30613144
[TBL] [Abstract][Full Text] [Related]
19. Design of multifunctional magnetic iron oxide nanoparticles/mitoxantrone-loaded liposomes for both magnetic resonance imaging and targeted cancer therapy.
He Y; Zhang L; Zhu D; Song C
Int J Nanomedicine; 2014; 9():4055-66. PubMed ID: 25187709
[TBL] [Abstract][Full Text] [Related]
20. Probing and Enhancing Ligand-Mediated Active Targeting of Tumors Using Sub-5 nm Ultrafine Iron Oxide Nanoparticles.
Xu Y; Wu H; Huang J; Qian W; Martinson DE; Ji B; Li Y; Wang YA; Yang L; Mao H
Theranostics; 2020; 10(6):2479-2494. PubMed ID: 32194814
[No Abstract] [Full Text] [Related]
[Next] [New Search]
